ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on Novemb... (d injury. This press release contains...)

ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008

Date:10/31/2008

d injury.

This press release contains forward-looking statements, and such statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual outcomes to differ materially from those contemplated by the forward-looking statements. Several factors, including timing of FDA approvals, changes in customer forecasts, our failure to meet customers' purchase order and quality requirements, supply shortages, production delays, changes in the markets for customers' products, introduction timing and acceptance of our new products scheduled for fiscal year 2009, and introduction of competitive products and other factors beyond our control, could result in a materially different revenue outcome and/or in our failure to achieve the revenue levels we expect for fiscal 2009. A more complete description of these and other risks that could cause actual events to differ from the outcomes predicted by our forward-looking statements is set forth under the caption "Risk Factors" in our annual report on Form 10-K and other reports we file with the Securities and Exchange Commission from time to time, and you should consider each of those factors when evaluating the forward-looking statements.

ThermoGenesis Corp.

Web site: http://www.thermogenesis.com

Contact: Investor Relations

+1-916-858-5107, or

ir@thermogenesis.com

0

GOOD

Page: 1 2
Related biology technology :

1. ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
2. ThermoGenesis Reports Record Quarterly Revenues of $7.2 Million; Full Year Revenues Increase 31 Percent
3. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
4. ThermoGenesis Names Tiffany Olson to Board of Directors
5. ThermoGenesis Announces FDA Authorization to Market MarrowXpress(TM) (MXP(TM))
6. ThermoGenesis Announces Receipt of CE Mark for MarrowXpress(TM)
7. ThermoGenesis Names Dr. Mahendra Rao to Board of Directors
8. ThermoGenesis Subsidiary Vantus Announces Stem Cell Agreement With UC Davis Center For Equine Health
9. ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
10. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
11. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008

Post Your Comments:

ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on Novemb...(d injury. This press release contains...)